// App-Quantinova.ai

422 : Venous thromboembolism (VTE) risk in patients with localized urinary tract tumors (UTT).

Researchers

Presenter

  • Jorge Ramos

Principal Investigators

  • Simon J. Crabb

  • Guenter Niegisch

  • Joaquim Bellmunt

  • Sylvain Ladoire

  • Syed A. Hussain

  • Jack Baniel

  • Ali Reza Golshayan

  • Thomas Powles

  • Jonathan E. Rosenberg

  • Ugo De Giorgi

  • Ulka N. Vaishampayan

  • Neeraj Agarwal

  • Sumanta K. Pal

  • Lauren Christine Harshman

  • Andrea Necchi

  • Federica Recine

  • Matt D. Galsky

  • Evan Y. Yu

Medical Centers

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Fox Chase Cancer Center, Temple University Hospital, Philadelphia, PA

  • University of Southampton, Southampten, United Kingdom

  • Department of Urology, Heinrich-Heine-University, Duesseldorf, Germany

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • Georges-Francois Leclerc Cancer Center, Dijon, France

  • University of Liverpool, Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, United Kingdom

  • Rabin Medical Center, Petach Tikvah, Israel

  • Carolina Oncology Associates PA, Hickory, NC

  • Barts Cancer Institute, Barts Health, and The Royal Free London NHS Foundation Trust, London, United Kingdom

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

  • Karmanos Cancer Institute, Wayne State University, Detroit, MI

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT

  • City of Hope, Duarte, CA

  • Stanford School of Medicine, Stanford, CA

  • Istituto Nazionale Tumori, Milano, Italy

  • Department of Medical Oncology, San Camillo and Forlanini Hospitals, Rome, Italy

  • The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

Locations

  • United States

  • United Kingdom

  • Germany

  • France

  • Israel

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A